KRT19 and non-small cell lung carcinoma: KRT19, on the other hand, which is expressed by both LUAD and LUSC, did not show any correlation with the grafting efficiency [29], despite the fact that it has been shown to be an excellent marker for the detection of lymph node metastases of NSCLC [30].